Prevention of Stroke: Carotid Artery Stenting or Endarterectomy?

Original Title: Long-Term Outcome after Carotid Artery Stenting. A Population-Based Matched Cohort Study.

Reference: Stroke. 2016 Jul 12. [Epub ahead of print].

 

Carotid Artery Stenting EndarterectomyIn the prevention of stroke, carotid artery stenting (CAS) is far less invasive than endarterectomy, but its long term outcomes remain unclear.

This large cohort study compared the long term outcomes of CAS vs. endarterectomy.

All patients included in the Swedvasc registry (National Swedish Vascular Registry) treated with CAS between 2005 and 2012 were identified. For every CAS procedure, 2 control endarterectomy procedures were included, matched by:

 

  • sex
  • age
  • year of procedure
  • indication (symptomatic/asymptomatic).

Primary end point was ipsilateral stroke, or death 30 days after procedure.

A total 1157 patients were included (409 CAS and 748 endarterectomy). Median age was 70 and 69% were symptomatic.

Risk factors were similar in both groups and the population was followed up at mean 4.1 years.

Death or stroke rates beyond the 30 days perioperative period occurred in:

  • 95 of 394 CAS patients (25.7%)
  • 120 of 724 endarterectomy patients (18.6%)

[Adjusted risk 1.59; CI 95% 1.15–2.18]

Death rate was:

  • 25.7% with CAS
  • 18.6% with endarterectomy

[HR 1.20; CI 95% 0.84–1.72]

Ipsilateral stroke rate was:

  • 9.4% with CAS
  • 2.9% with endarterectomy

[HR 3.40; CI 95% 1.53–7.53]

Any stroke + death after 30 days was:

  • 34.2% with CAS
  • 23.6% with endarterectomy

[HR 1.49; CI 95% 1.10–2.00]

 

Conclusion

In this cohort study, CAS was associated with a long term increased risk of ipsilateral stroke and death after perioperative period compared to endarterectomy.

 

Editorial Comment

Even though population was matched, some characteristics may be misleading in this kind of studies. Higher mortality in the CAS group cannot be explained by excessive ipsilateral stroke and may be due to higher global risk, which may have favored CAS indication, being less invasive.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...